aTyr Pharma Inc reports results for the quarter ended in March - Earnings Summary

aTyr Pharma

09/05/2023 21:21

* aTyr Pharma Inc  LIFE.OQ  reported a quarterly adjusted
loss
of 29 cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 40
cents per share.
    * Reported revenue was zero​; analysts expected $303.33
thousand. 
    * aTyr Pharma Inc's reported EPS for the quarter was a loss
of 29
cents​.
    * The mean earnings estimate of analysts had risen by
about 24.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * aTyr Pharma Inc shares had risen by 1.9% this quarter and
lost 2.3% so far this year.
    * The company reported a quarterly loss of $11.96 million.
    * Wall Street's median 12-month price target for aTyr Pharma
Inc
is $17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 08:21 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.40          -0.29          Beat
 Dec. 31 2022      -0.48          -0.26          Beat
 Sep. 30 2022      -0.46          -0.46          Met
 Jun. 30 2022      -0.38          -0.44          Missed